의약품(최종 제제) 수탁제조 업계 : 구조, 규모, 시장 점유율, 향후 전망(2023년판)

Abstract

This expert trend report is a comprehensive look at the pharmaceutical finished dose contract manufacturing landscape in 2023, including analysis of dose CMO M&A activity, market size and share. It is a critical source for strategic planning efforts and will improve understanding of crucial components of the supply chain that will provide insights for supplier selection and management.

This expert trend report is a comprehensive look at the finished dose contract manufacturing landscape in 2023, including analysis of dose CMO M&A activity, market size and share. It is a critical source for strategic planning efforts and will improve understanding of crucial components of the supply chain that will provide insights for supplier selection and management.

Scope

This 63-page report gives an important expert quantitative analysis on the pharmaceutical commercial contract dose manufacturing industry. Findings are based on the industry's most comprehensive database of the dose CMO industry (GlobalData's Contract Service Providers Database). This analysis is driven by a proprietary model of the dose manufacturing industry, which is continuously updated and refined. The 8 tables and 20 figures throughout the report illustrate major points and trends. This report is required reading for -

• CMO executives and strategic decision-makers: to improve understanding of the dose CMO industry and provide a critical input for strategic planning efforts.
• Sourcing and procurement executives in bio/pharmaceutical companies: to improve understanding of crucial components of the supply base that will provide insights for supplier selection and management.
• Private equity investors: they can gain a deeper understanding of the dose CMO market and important insights for identifying potential investment targets.

Reasons to Buy

This report will enable the user to answer the following questions -

• What is the geographic reach of commercial dose CMOs?
• What are revenues did the commercial contract dose manufacturing industry generate in the last year?
• What are the components of revenue change for contract dose manufacturers?
• What is the breakdown of 2022 revenues by different dosage forms?
• What are the characteristics of the largest dose CMOs?
• How did the revenue growth of Contract Dose manufacturers in 2022 compare to Contract API manufacturers?
• What is the outlook for the dose CMO industry?
• What is the outlook for COVID-19 products?

Table of Contents

Table of Contents

• About GlobalData

Table of Contents

• Executive Summary
• Players
• Trends
• Industry size and structure
• Definition of the dose CMO universe
• Industry demographics
• Global vs regional reach
• Dosage forms
• Major developments affecting industry structure
• Dose facility acquisitions
• Dose company acquisitions
• PE acquisitions
• Industry size and growth
• Dose manufacturing
• Inflation
• Components of growth
• Revenue by dosage form
• CMO market shares
• Characteristics of the largest CMOs
• COVID-19 Products Sales Forecast
• Analyzing Recent Dose CMO Industry Performance
• COVID-19 Influence
• High Inflation Effect
• Service-Specific Growth
• Cell and gene therapy investment
• Sponsor-CMO relationships
• What it means
• Value Chain
• Companies

Appendix

• Methodology
• Methodology for market size and growth estimates
• CMO classifications
• Bibliography
• Primary research - key opinion leaders
• Further reading
• About the Authors
• Contact Us